The NHS has provided guidance on identifying flu symptoms, which can emerge very rapidly and include a sudden high ...
The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...
If RSV develops into a more serious infection such as pneumonia or bronchiolitis, it may also cause a worsening cough, ...
Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical ...
Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive ...
CANDELA Reybauld has spent her whole life breathing through a partially blocked nostril. The mum-of-two was left stunned ...
A new study published in the journal of Arthritis & Rheumatology revealed that patients with rheumatoid arthritis-associated ...
As cold weather sets in, viruses such as influenza, RSV, and COVID-19 are resurfacing. Quickly identifying symptomatic individuals is an essential part of any strategy to fight their spread. Yet, ...
Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results